Loading...
G

Guardion Health Sciences Inc
NASDAQ:GHSI

Watchlist Manager
Guardion Health Sciences Inc
NASDAQ:GHSI
Watchlist
Price: 0.17 USD Market Closed
Updated: Dec 6, 2022

Intrinsic Value

GHSI doesn't have a meaningful market cap.

The intrinsic value of one GHSI stock under the Base Case scenario is 0.49 USD. Compared to the current market price of 0.17 USD, Guardion Health Sciences Inc is Undervalued by 65%.

The Intrinsic Value is calculated as the average of the two valuation methods:

GHSI Intrinsic Value
Base Case
0.49 USD
Undervaluation 65%
Intrinsic Value
Price
G
Worst Case
Base Case
Best Case

Fundamental Analysis

GHSI Profitability Score
Profitability Due Diligence

Guardion Health Sciences Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

Negative 3-Year Average ROE
Negative 3-Year Average ROIC
Negative Free Cash Flow
Negative Operating Income
36/100
Profitability
Score

Guardion Health Sciences Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

GHSI Solvency Score
Solvency Due Diligence

Guardion Health Sciences Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Low Altman Z-Score
Short-Term Liabilities
Long-Term Liabilities
Low D/E
61/100
Solvency
Score

Guardion Health Sciences Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Financials
Efficiency
42%
Gross Margin
-80%
Operating Margin
-188%
Net Margin
-70%
FCF Margin
-65%
ROE
-42%
ROIC
Other

GHSI Capital Structure
Guardion Health Sciences Inc

Market Capitalization 10.5M USD
Total Debt 0 USD
Minority Interest 0 USD
Preferred Equity 0 USD
Cash and Equivalents 12.9M USD
Short-Term Investments 0 USD
Enterprise Value -2.5M USD

Wall St
Price Targets

GHSI Price Targets Summary
Guardion Health Sciences Inc

Wall Street analysts forecast GHSI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GHSI is 0.71 USD with a low forecast of 0.61 USD and a high forecast of 0.84 USD.

Lowest
Price Target
0.61 USD
256% Upside
Average
Price Target
0.71 USD
320% Upside
Highest
Price Target
0.84 USD
394% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

GHSI Competitors
Guardion Health Sciences Inc

GHSI Suppliers & Customers
Guardion Health Sciences Inc

Guardion Health Sciences Inc has 1 key suppliers from 1 countries and 1 industries. The majority of these suppliers are located in the United States of America, with the largest number of suppliers in the Retail industry.

United States of America
1
Suppliers Map

Guardion Health Sciences Inc has 4 key customers from 1 countries and 2 industries. The majority of these customers are located in the United States of America, with the largest number of customers in the Retail industry.

Ownership

GHSI Insider Trading
Buy and sell transactions by insiders

Guardion Health Sciences Inc insiders have not made purchase/sale transactions in the past 12 months.

During the last 12 months Guardion Health Sciences Inc insiders have not bought any shares, and have not sold any shares. The last transaction was made on Dec 6, 2022 by Scholtes Bret (CEO and President), who bought 6.8k USD worth of GHSI shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
No Insider Transactions
0
0 USD
Cumulative Transactions Amount
Period Sold Bought Net
3 Months
N/A
N/A
N/A
6 Months
N/A
N/A
N/A
9 Months
N/A
N/A
N/A
12 Months
N/A
N/A
N/A
Purchases
4
Sales
0
Why is insider trading important?

Shareholder Return

GHSI Price
Guardion Health Sciences Inc

1M 1M
+0%
6M 6M
+0%
1Y 1Y
-82%
3Y 3Y
-86%
5Y 5Y
-99%
Annual Price Range
0.17
52w Low
0.14
52w High
1.03
Price Metrics
Average Annual Return 5.06%
Standard Deviation of Annual Returns 138.97%
Max Drawdown -99%
Shares Statistics
Market Capitalization 10.5M USD
Shares Outstanding 61 600 800
Percentage of Shares Shorted 9.16%

Company Profile

Guardion Health Sciences Inc

Country

United States of America

Industry

Consumer products

Market Cap

10.5M USD

Dividend Yield

0%

Description

Guardion Health Sciences, Inc.is a clinical nutrition and diagnostics company, which develops medical foods and medical devices in the ocular health space and develops nutraceutical products to provide supportive health benefits to consumers. The company is headquartered in Houston, Texas and currently employs 13 full-time employees. The company went IPO on 2019-04-05. The firm offers a portfolio of science-based, clinically supported products and devices designed to support healthcare professionals and providers, and their patients and consumers. The Company, through Activ Nutritional, LLC (Activ), owns the Viactiv line of supplement chews for bone health, immune health, and other applications. The Viactiv line of supplements contains several flavored nutritional supplement products, but the milk chocolate and caramel-flavored calcium chews constitute the main product category. The company also sells Lumega-Z, its medical food product that has a formula designed to replenish and restore the macular protective pigment, simultaneously delivering critical and essential nutrients to the eye. The firm's GlaucoCetin, a medical food, which offers a formula that is designed to support proper mitochondrial function in the optic nerve cells in glaucoma patients.

Contact

TEXAS
Houston
2925 Richmond Avenue, Suite 1200
+18008735141.0
http://guardionhealth.com/

IPO

2019-04-05

Employees

13

Officers

Independent Chairman & Sec.
Mr. Robert Neal Weingarten
Pres, CEO & Director
Mr. Bret D. Scholtes
Chief Commercial Officer
Mr. Craig J. Sheehan
Chief Accounting Officer
Mr. Jeffrey Benjamin

See Also

Similar Stocks
What is the Intrinsic Value of one GHSI stock?

The intrinsic value of one GHSI stock under the Base Case scenario is 0.49 USD.

Is GHSI stock undervalued or overvalued?

Compared to the current market price of 0.17 USD, Guardion Health Sciences Inc is Undervalued by 65%.